Myriad Genetics MYGN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $126M-16.7% | $151.3M-2.3% | $154.8M+84.9% | $83.7M-17.1% | $101M-9.7% | ||
| $123.8M+7.4% | $115.3M-2.3% | $118M-13.9% | $137M+13.8% | $120.4M-0.7% | ||
| $27.9M-8.8% | $30.6M-3.2% | $31.6M+10.1% | $28.7M+1.4% | $28.3M+2.9% | ||
| $312.8M-6.0% | $332.6M-3.5% | $344.8M+21.3% | $284.3M-1.0% | $287.2M-3.6% | ||
| $111.5M-2.2% | $114M+2.3% | $111.4M-1.4% | $113M-0.9% | $114M-2.9% | ||
| $47.1M-8.7% | $51.6M0.0% | $51.6M0.0% | $51.6M-82.0% | $286.3M0.0% | ||
| $145.7M-5.0% | $153.4M-5.9% | $163.1M-4.1% | $170.1M-33.9% | $257.5M-1.9% | ||
| $673.7M-4.7% | $706.6M-3.0% | $728.1M+7.5% | $677.3M-32.7% | $1.01B-2.1% | ||
| $32.6M+8.7% | $30M-5.7% | $31.8M+2.9% | $30.9M+10.0% | $28.1M-13.0% | ||
| $130.2M-2.7% | $133.8M-9.6% | $148M-26.0% | $199.9M+32.3% | $151.1M-7.9% | ||
| $120.3M+0.3% | $119.9M+0.3% | $119.5M— | $0-100% | $59.3M+49.7% | ||
| $336.3M-0.7% | $338.6M-4.7% | $355.3M+22.9% | $289.2M-4.0% | $301.2M-7.7% | ||
| 150M+16,567% | 900K-99.4% | 150M0.0% | 150M0.0% | 150M+16,567% | ||
| -$1.16B-3.0% | -$1.12B-0.7% | -$1.11B-2.5% | -$1.09B-43.7% | -$756.9M0.0% | ||
| $337.4M-8.3% | $368M-1.3% | $372.8M-3.9% | $388.1M-44.9% | $704.9M+0.5% | ||
| $673.7M-4.7% | $706.6M-3.0% | $728.1M+7.5% | $677.3M-32.7% | $1.01B-2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Myriad Genetics's total assets?
- Myriad Genetics (MYGN) holds $673.7M in total assets, down 33.0% year over year.
- How much debt does Myriad Genetics have?
- Myriad Genetics carries $211.5M in total debt against $337.4M of shareholders' equity, a debt-to-equity ratio of 0.63.
- How much cash does Myriad Genetics have?
- Myriad Genetics holds $126.0M in cash and equivalents.
- Can Myriad Genetics cover its short-term obligations?
- Its current ratio is 2.40 — current assets exceed current liabilities.
- Where does Myriad Genetics's balance sheet data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
